JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 37:1877-1882
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moustapha, A.
Right arrow Articles by Anderson, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moustapha, A.
Right arrow Articles by Anderson, H. V.

CLINICAL STUDY: INTERVENTIONAL CARDIOLOGY

Percutaneous and surgical interventions for in-stent restenosis: long-term outcomes and effect of diabetes mellitus

Ali Moustapha, MD*, Abid R. Assali, MD*, Stefano Sdringola, MD*, William K. Vaughn, PhD{dagger}, R. David Fish, MD, FACC{dagger}, Oscar Rosales, MD, FACC*, George Schroth, MD, FACC*, Zvonimir Krajcer, MD, FACC{dagger}, Richard W. Smalling, MD, PhD, FACC* and H. Vernon Anderson, MD, FACC*

* University of Texas Medical School at Houston, Houston, Texas, and Memorial Hermann Hospital, Houston, Texas, USA
{dagger} Texas Heart Institute, Houston, Texas, and St. Luke’s Episcopal Hospital, Houston, Texas, USA

Manuscript received September 12, 2000; revised manuscript received February 1, 2001, accepted February 15, 2001.

Reprint requests and correspondence: Dr. H. Vernon Anderson, University of Texas Medical School at Houston, MSB 1.246, 6431 Fannin, Houston, Texas 77030
h.v.anderson{at}uth.tmc.edu

OBJECTIVE

We examined long-term outcomes of patients with in-stent restenosis (ISR) who underwent different percutaneous interventions at the discretion of individual operators: balloon angioplasty (BA), repeat stent or rotational atherectomy (RA). We also examined long-term outcomes of patients with ISR who underwent coronary artery bypass surgery (CABG).

BACKGROUND

In-stent restenosis remains a challenging problem, and its optimal management is still unknown.

METHODS

Symptomatic patients (n = 510) with ISR were identified using cardiac catheterization laboratory data. Management for ISR included BA (169 patients), repeat stenting (117 patients), RA (107 patients) or CABG (117 patients). Clinical outcome events of interest included death, myocardial infarction, target vessel revascularization (TVR) and a combined end point of these major adverse cardiovascular events (MACE). Mean follow-up was 19 ± 12 months (range = 6 to 61 months).

RESULTS

Patients with ISR treated with repeat stent had significantly larger average post-procedure minimal lumen diameter compared with BA or RA (3.3 ± 0.4 mm vs. 3.0 ± 0.4 vs. 2.9 ± 0.5, respectively, p < 0.05). Incidence of TVR and MACE were similar in the BA, stent and RA groups (39%, 40%, 33% for TVR and 43%, 40%, 33% for MACE, p = NS). Patients with diabetes who underwent RA had similar outcomes as patients without diabetes, while patients with diabetes who underwent BA or stent had worse outcomes than patients without diabetes. Patients who underwent CABG for ISR, mainly because of the presence of multivessel disease, had significantly better outcomes than any percutaneous treatment (8% for TVR and 23% for MACE).

CONCLUSIONS

In this large cohort of patients with ISR and in the subset of patients without diabetes, long-term outcomes were similar in the BA, repeat stent and RA groups. Tissue debulking with RA yielded better results only in diabetic patients. Bypass surgery for patients with multivessel disease and ISR provided the best outcomes.

Abbreviations and Acronyms
  BA = balloon angioplasty
  CABG = coronary artery bypass graft surgery
  ISR = in-stent restenosis
  LAD = left anterior descending artery
  MACE = major adverse cardiovascular events
  MI = myocardial infarction
  MLD = minimal lumen diameter
  RA = rotational atherectomy
  TVR = target vessel revascularization




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
B. Yilmazkaya, R. Circi, U. P. Circi, S. Gurkahraman, M. A. Yukselen, O. Z. Yondem, and O. Tasdemir
Surgical approaches in left anterior descending artery in-stent stenosis.
Ann. Thorac. Surg., May 1, 2008; 85(5): 1586 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Fukui, S. Takanashi, and Y. Hosoda
Coronary Endarterectomy and Stent Removal in Patients With In-Stent Restenosis
Ann. Thorac. Surg., February 1, 2005; 79(2): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H.-K. Yip, C.-J. Wu, C.-H. Yang, H.-W. Chang, S.-M. Chen, W.-C. Hung, and C.-L. Hang
Delayed Post-Myocardial Infarction Invasive Measures, Helpful or Harmful?: A Subgroup Analysis
Chest, July 1, 2004; 126(1): 38 - 46.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.